TH165384A - - Google Patents
Info
- Publication number
- TH165384A TH165384A TH1601003068A TH1601003068A TH165384A TH 165384 A TH165384 A TH 165384A TH 1601003068 A TH1601003068 A TH 1601003068A TH 1601003068 A TH1601003068 A TH 1601003068A TH 165384 A TH165384 A TH 165384A
- Authority
- TH
- Thailand
- Prior art keywords
- compound
- losartan
- pharmaceutical
- amlodipine
- rosuvastatin
- Prior art date
Links
- 239000002083 C09CA01 - Losartan Substances 0.000 claims abstract 13
- KJJZZJSZUJXYEA-UHFFFAOYSA-N Losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 claims abstract 13
- 229960004773 Losartan Drugs 0.000 claims abstract 13
- HTIQEAQVCYTUBX-UHFFFAOYSA-N Amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 claims abstract 10
- 229960000528 amlodipine Drugs 0.000 claims abstract 10
- BPRHUIZQVSMCRT-VEUZHWNKSA-N Rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 claims abstract 9
- 229960000672 rosuvastatin Drugs 0.000 claims abstract 9
- 150000001875 compounds Chemical class 0.000 claims abstract 8
- 238000009472 formulation Methods 0.000 claims abstract 8
- 239000000203 mixture Substances 0.000 claims abstract 8
- 239000004480 active ingredient Substances 0.000 claims abstract 4
- -1 compound compound Chemical class 0.000 claims abstract 4
- 238000004090 dissolution Methods 0.000 claims abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 4
- 238000005020 pharmaceutical industry Methods 0.000 claims abstract 4
- 206010003210 Arteriosclerosis Diseases 0.000 claims abstract 2
- 208000008787 Cardiovascular Disease Diseases 0.000 claims abstract 2
- 201000001320 atherosclerosis Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 230000003993 interaction Effects 0.000 claims abstract 2
- 230000014759 maintenance of location Effects 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 239000000654 additive Substances 0.000 claims 1
Publications (3)
Publication Number | Publication Date |
---|---|
TH165384A true TH165384A (es) | 2017-07-27 |
TH1601003068A TH1601003068A (th) | 2017-07-27 |
TH165384B TH165384B (th) | 2017-07-27 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501079A1 (en) | 1,3-thiazol-2-yl substituted benzamides | |
MD20170070A2 (ro) | Derivaţi de chinazolină utilizaţi în tratamentul HIV | |
MX2018010301A (es) | Sales de derivados de piperazina obtenidas por adicion de acidos. | |
TN2016000081A1 (en) | Aminoheteroaryl benzamides as kinase inhibitors | |
PH12017502051A1 (en) | TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF | |
AR128459A2 (es) | Composición farmacéutica sólida comprimida por rodillo y el proceso para su fabricación | |
MX2018004304A (es) | DERIVADOS DE QUINOXALINA Y PIRIDOPRAZINA COMO INHIBIDORES DE PI3Kß. | |
PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
AR090073A1 (es) | N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos | |
CL2016003063A1 (es) | Composición basada en una solución estabilizada de ingredientes activos | |
TR201909422T4 (tr) | Flurbiprofen ve dekspantenolün oral topikal sulu farmasötik bileşimleri. | |
WO2016020408A3 (en) | Compounds for preventing ototoxicity | |
TH165384A (es) | ||
AR107163A1 (es) | Inhibidores de quinasa | |
MX2017010323A (es) | Formulaciones farmaceuticas de inhibidor de esterasa c1. | |
TH165384B (th) | สูตรผสมสารรวมทางเภสัชกรรมที่ประกอบรวมด้วยแอมโลดิปีน, ลอซาร์แทน และโรซูวาสแตติน | |
PE20161345A1 (es) | Composicion antifungica topica para el tratamiento de onicomicosis | |
WO2014193696A3 (en) | Benzimidazole carboxylic acid derivatives, compositions, and methods of use as aurora kinase inhibitors | |
TH1801003854A (th) | ยาเตรียมแบบคอมโพสิตทางเภสัชกรรม | |
CO2016004668A2 (es) | Composición basada en una solución estabilizada de ingredientes activos | |
TH173507A (th) | อนุพันธ์ชนิดวงเชื่อมของไดไฮโดรไพริมิโดในฐานะสารยับยั้ง hbv | |
MA38973B1 (fr) | Aminohétéroaryles benzamides en tant qu'inhibiteurs de kinase | |
TH1601004492A (th) | สารประกอบเตตระไฮโดรไพริโดไพริมิดีนใหม่หรือเกลือของมัน | |
TH180431A (th) | อนุพันธ์ไบไซคลิก เฮทเทอโรไซคลิก ในรูปสารยับยั้งโบรโมโดเมน | |
TH1801000990A (th) | แอนนีเลทเต็ดฟีนอกซีอะเซตาไมด์แบบใหม่ |